Evidence map›Paper›PMID 42170850›Full record

ReviewEssays in biochemistry2026

Bacterial biosynthetic superclusters: emerging drivers of synergistic natural products against antimicrobial resistance.

Karla Alexa Pentón, Yvonne Mast, Beatriz Cámara

Abstract readReview
In one paragraph

Review in Essays in biochemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Bacterial biosynthetic gene clusters.Essays in biochemistry · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Karla Alexa PentónPrograma de Doctorado en Biotecnología, Pontificia Universidad Católica de Valparaíso and Universidad Técnica Federico Santa María, Valparaíso, Chile.ORCID 0009-0006-6356-6679
Yvonne MastLeibniz Institute DSMZ - German Collection of Microorganisms and Cell Cultures GmbH, Inhoffenstraße 7B, 38124 Braunschweig, Germany.ORCID 0000-0003-3099-5777
Beatriz CámaraActinoLab USM, Center of Biotechnology "Daniel Alkalay Lowitt" & Department of Chemistry, Universidad Técnica Federico Santa María, Avenida España 1680, 2390136 Valparaíso, Chile.ORCID 0000-0001-5227-7499

Funding

Agencia Nacional de Investigación y Desarrollo (ANID) 21232059ANID | Fondo Nacional de Desarrollo Científico y Tecnológico (FONDECYT) 1221264Universidad Técnica Federico Santa María (UTFSM) N/A
6 · The paper itself

Abstract

Antimicrobial resistance (AMR) is a critical threat to global health and the economy. A promising strategy to address this challenge is the exploration of synergistic combinations of natural antimicrobials, which can broaden antibiotic spectra, enhance efficacy, and reduce the likelihood of resistance development. Such combinations often arise in bacteria through complex metabolic pathways encoded by biosynthetic superclusters (BSs)-genomic arrangements in which multiple biosynthetic gene clusters (BGCs) co-localize within the same genomic region, promoting co-regulation and co-production of specialized metabolites with complementary activities. This review provides an overview of current knowledge on biosynthetic gene superclusters in bacteria, focusing on their genomic architectures, regulatory connectivity, and the synergistic interaction profiles of the encoded metabolites as shaped by evolutionary pressures. Finally, we highlight how integrative genome-metabolome mining can be applied to discover, validate, and reprogram supercluster genes, positioning them as promising, naturally evolved platforms for the rational design of modular antimicrobial combinations to help combat AMR.

Indexed as

Anti-Bacterial AgentsBacteriaBiological ProductsDrug Resistance, BacterialBiosynthetic PathwaysMultigene FamilyAnti-Bacterial AgentsBiological ProductsBacterial biosynthetic superclustersCo-producing metabolitesSynergistic natural products

Identifiers

PMID42170850
PMCPMC13500783

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.